Ayala Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2002
Net Income	-48.07	-14.36	-17.86	-26.47	-17.79	-66.52	-93.44	-73.56	-47.03	-16.53	Upgrade
Depreciation & Amortization	0.37	0.31	0.99	1.98	0.15	1.5	1.12	0.54	0.27	0.2	Upgrade
Share-Based Compensation	1.22	2.24	0.57	0.89	0.73	6.99	27.84	23.47	0	0	Upgrade
Other Operating Activities	17	-3.48	0.87	1.66	1.97	-4.11	-12.44	40.48	22.63	-0.7	Upgrade
Operating Cash Flow	-29.49	-15.28	-15.44	-21.94	-14.95	-62.13	-76.92	-9.07	-24.14	-17.02	Upgrade
Capital Expenditures	0	-0.2	-0.46	-0.75	-1.33	-2.84	-4.62	-4.45	-1.79	-0.44	Upgrade
Acquisitions	1.91	0.04	0.45	0	0.08	-1.42	1.17	1.23	0	0	Upgrade
Change in Investments	-	-	-	-0.23	-	-71.38	-135.11	-95.05	-45.66	-	Upgrade
Other Investing Activities	4.04	-	-	0.23	-0.33	118.81	126.1	99.83	-	-	Upgrade
Investing Cash Flow	5.95	-0.17	-0.01	-0.75	-1.58	43.17	-12.45	1.56	-47.45	-0.44	Upgrade
Common Stock Issued	20	4.31	28.12	15.5	24.57	39.71	2.51	55.88	120.9	14.58	Upgrade
Share Repurchases	0	-5.25	0	0	0	0	0	0	0	0	Upgrade
Other Financing Activities	6	-10.52	3.77	0.01	-17.5	-0.51	-1.98	-2.18	-0.36	-0.06	Upgrade
Financing Cash Flow	26	-0.96	31.89	15.5	7.08	39.2	0.53	53.7	120.54	14.52	Upgrade
Net Cash Flow	2.49	-16.41	16.44	-7.19	-9.46	20.24	-88.85	46.19	48.95	-2.95	Upgrade
Free Cash Flow	-29.49	-15.49	-15.9	-22.69	-16.28	-64.97	-81.55	-13.52	-25.93	-17.46	Upgrade
Free Cash Flow Margin	-226807.69%	-6194.00%	-490.71%	-8967.59%	-697.51%	-1071.58%	-677.80%	-338.43%	-	-1746.13%	Upgrade
Free Cash Flow Per Share	-4.90	-8.51	-9.85	-29.75	-85.64	-1513.22	-2414.54	-458.30	-1110.27	-1224.93	Upgrade

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.